Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 42503 

Background and Brief Description 

The Centers for Disease Control and 

Prevention’s (CDC), National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Division of Global 

Migration and Quarantine (DGMQ), 

Immigrant, Refugee, and Migrant Health 

Branch (IRMH), requests approval for a 

revision of an existing information 

collection. This project pertains to 

collecting annual reports on certain 

tuberculosis data from U.S. panel 

physicians. 

The respondents are panel physicians. 

More than 760 panel physicians from 

336 panel sites perform overseas predeparture medical examinations in 

accordance with requirements, referred 

to as technical instructions, provided by 

DGMQs Quality Assessment Program 

(QAP). The role of QAP is to assist and 

guide panel physicians in the 

implementation of the Technical 

Instructions; evaluate the quality of the 

overseas medical examination for U.S.- 

bound immigrants and refugees; assess 

potential panel physician sites; and 

provide recommendations to the U.S. 

Department of State in matters of 

immigrant medical screening. 

To achieve DGMQ’s mission, the 

Immigrant, Refugee and Migrant Health 

branch (IRMH) works with domestic 

and international programs to improve 

the health of U.S.-bound immigrants 

and refugees to protect the U.S. public 

by preventing the importation of 

infectious disease. These goals are 

accomplished through IRMH’s oversight 

of medical exams required for all U.S.- 

bound immigrants and refugees who 

seek permanent residence in the U.S. 

IRMH is responsible for assisting and 

training the international panel 

physicians with the implementation of 

medical exam Technical Instructions 

(TI). Technical Instructions are detailed 

requirements and national policies 

regarding the medical screening and 

treatment of all U.S.-bound immigrants 

and refugees. 

Screening for tuberculosis (TB) is a 

particularly important component of the 

immigration medical exam and allows 

panel physicians to diagnose active TB 

disease prior to arrival in the United 

States. As part of the Technical 

Instructions requirements, panel 

physicians perform chest x-rays and 

laboratory tests that aid in the 

identification of tuberculosis infection 

(Class B1 applicants) and diagnosis of 

active tuberculosis disease (Class A, 

inadmissible applicants). CDC uses 

these classifications to report new 

immigrant and refugee arrivals with a 

higher risk of developing TB disease to 

U.S. state and local health departments 

for further follow-up. Some information 

that panel physicians collect as part of 

the medical exam is not reported on the 

standard Department of State forms (DSforms), thereby preventing CDC from 

evaluating TB trends in globally mobile 

populations and monitoring program 

effectiveness. 

Currently, CDC is requesting this data 

be sent by panel physicians once per 

year. The consequences of reducing this 

frequency would be the loss of 

monitoring program impact and TB 

burdens in mobile populations and 

immigrants and refugees coming to the 

United States on an annual basis. The 

total hours requested is 1,008. There is 

no cost to the respondents other than 

their time. 

Estimated annual burden is being 

reduced by 1,640 hours per year. The 

number of respondents is being reduced 

by 17. Reductions are due to revised 

estimates on burden time per response, 

and the removal of four variables from 

the data collection form and improved 

IT capacity at most panel sites. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

International panel physicians .......... TB Indicators Excel Spreadsheet .... 336 1 3 1,008 

Total ........................................... ........................................................... ........................ ........................ ........................ 1,008 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–18054 Filed 8–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–18–0338; Docket No. CDC–2018– 

0076] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS) 

ACTION: Notice with comment period 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing efforts to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed work and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a continuing information 

collection project titled Annual 

Submission of the Ingredients Added to, 

and the Quantity of Nicotine Contained 

in, Smokeless Tobacco Manufactured, 

Imported, or Packaged in the U.S. 

DATES: CDC must receive written 

comments on or before October 22, 

2018. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2018– 

0076 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 


amozie on DSK3GDR082PROD with NOTICES1
42504 Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Under the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3501–3520), 

Federal agencies must obtain approval 

from the Office of Management and 

Budget (OMB) for each collection of 

information they conduct or sponsor. In 

addition, the PRA also requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each new proposed 

collection, each proposed extension of 

existing collection of information, and 

each reinstatement of previously 

approved information collection before 

submitting the collection to the OMB for 

approval. To comply with this 

requirement, we are publishing this 

notice of a proposed data collection as 

described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Annual Submission of the Ingredients 

Added to, and the Quantity of Nicotine 

Contained in, Smokeless Tobacco 

Manufactured, Imported, or Packaged in 

the U. S.—Extension—National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

Smokeless tobacco products (SLT) are 

associated with many health problems. 

Using smokeless tobacco: Can lead to 

nicotine addiction; causes cancer of the 

mouth, esophagus, and pancreas; is 

associated with diseases of the mouth; 

can increase risks for early delivery and 

stillbirth when used during pregnancy; 

can cause nicotine poisoning in 

children; and, may increase the risk for 

death from heart disease and stroke. 

The CDC’s Office on Smoking and 

Health (OSH) has the primary 

responsibility for the HHS smoking and 

health program. As required by the 

Comprehensive Smokeless Tobacco 

Health Education Act of 1986 (CSTHEA, 

15 U.S.C. 4401 et seq., Pub. L. 99–252), 

CDC collects a list of ingredients added 

to tobacco in the manufacture of 

smokeless tobacco products and a 

specification of the quantity of nicotine 

contained in each product. HHS has 

delegated responsibility for 

implementing the required information 

collection to CDC’s OSH. Respondents 

are manufacturers, packagers, or 

importers (or their representatives) of 

smokeless tobacco products. 

Respondents are not required to submit 

specific forms; however, they are 

required to meet reporting guidelines 

and to submit the ingredient report by 

chemical name and Chemical Abstract 

Service (CAS) Registration Number, 

consistent with accepted reporting 

practices for other companies that are 

required to report ingredients added to 

other consumer products. Typically, 

respondents submit a summary report to 

CDC with the ingredient information for 

multiple products, or a statement that 

there are no changes to their previously 

submitted ingredient report. 

Respondents may submit the required 

information to CDC through a 

designated representative. The 

information collection is subject to strict 

confidentiality provisions. 

Ingredient reports for new SLT 

products are due at the time of first 

importation. Thereafter, ingredient 

reports are due annually on March 31. 

Information is submitted to CDC by 

mailing a written report on the 

respondent’s letterhead, by CD, threeinch floppy disk, or thumb drive. 

Electronic mail submissions are not 

accepted. Annual submission reports 

are mailed to Attention: FCLAA 

Program Manager, Office on Smoking 

and Health, National Center for Chronic 

Disease Prevention and Health 

Promotion, Centers for Disease Control 

and Prevention, 4770 Buford Highway 

NE, MS S107–7, Atlanta, GA 30341– 

3717. 

Upon receipt and verification of the 

annual nicotine and ingredient report, 

CDC issues a Certificate of Compliance 

to the respondent. As deemed 

appropriate by the Secretary of HHS, 

HHS is authorized to use the 

information to report to Congress the 

health effects of ingredients, research 

activities related to the health effects of 

ingredients, and other information that 

the Secretary determines to be of public 

interest. The estimated annual Burden 

Hours are 18,843. There are no costs to 

respondents other than their time. OMB 

approval is requested for three years. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Smokeless Tobacco Manufacturers, 

Packagers, and Importers.

SLT Nicotine and Ingredient and 

Report.

11 1 1,713 18,843 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 163 / Wednesday, August 22, 2018 / Notices 42505 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–18053 Filed 8–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Administration for Native Americans; 

Notice of Meeting 

AGENCY: Administration for Children 

and Families, Department of Health and 

Human Services. 

ACTION: Notice of Tribal Consultation. 

SUMMARY: The Department of Health and 

Human Services, Administration for 

Children and Families (ACF) will host 

a Tribal Consultation to consult on ACF 

programs and tribal priorities. 

DATES: September 13, 2018. 

ADDRESSES: Capital Skyline Hotel, 10 

‘‘I’’ (eye) Street SW, Washington, DC 

20024. 

FOR FURTHER INFORMATION CONTACT: 

Jeannie Hovland, Commissioner, 

Administration for Native Americans 

and Deputy Assistant Secretary for 

Native American Affairs at 202–401– 

5156, by email at anacommissioner@

acf.hhs.gov or by mail at 330 C Street 

SW, MS–4126, Washington, DC 20201. 

SUPPLEMENTARY INFORMATION: In 

accordance with the ACF Tribal 

Consultation Policy, ACF announces 

tribal consultation with tribal leaders 

operating ACF programs. 

The consultation will be conducted 

with elected or appointed leaders of 

tribal governments and their designated 

representatives. Designees must have a 

letter from the tribal government 

authorizing them to represent the tribe. 

Tribal governments must submit the 

designee letter at least 3 days in advance 

of the consultation session to the 

Administration for Native Americans at 

anacommissioner@acf.hhs.gov. Other 

representatives of tribal organizations 

and Native non-profit organizations are 

welcome to attend as observers. A report 

of the consultation session will be 

prepared and made available at the 

following website address within 45 

days after the closing of the consultation 

session. Tribes wishing to submit 

written testimony should send it to 

anacommissioner@acf.hhs.gov either 

prior to the consultation session or 

within 30 days after the meeting. ACF 

will summarize oral testimony and 

comments from the consultation session 

along with topics of concern and 

recommendations. 

ACF has identified the following 

topics for consultation: 

Family First Services Act 

Title IV–E Planning Grants—What 

barriers are preventing Tribes from 

applying for the grant 

Office of Head Start annual consultation 

TANF and Welfare reform 

The ACF Tribal Consultation Session 

will begin at 9:00 a.m. on September 13 

and continue throughout the day until 

all discussions have been completed. To 

help both you and the ACF Principals 

prepare for this consultation, planning 

teleconference calls will be held: 

Wednesday, August 22, 2018 @4:00 

p.m.–4:30 p.m. (EST) 

Thursday, August 23, 2018 @4:00 p.m.– 

4:30 p.m. (EST) 

Tuesday, August 28, 2018 @4:00 p.m.– 

4:30 p.m. (EST) 

The call-in number and passcode are: 

866–769–9393 passcode: 4449449#. 

The purpose of the planning calls will 

be to identify individuals who will 

provide oral testimony to ACF, solicit 

for tribal moderators and identify 

specific topics of interest so we can 

ensure that all appropriate individuals 

are present. 

For any tribe unable to attend in 

person, ACF will provide a webinar 

link, Please contact our 1–877–922– 

9ANA (1–877–922–9262) for the 

webinar information. 

We have set up a registration for all 

participants whether attending in 

person or by webinar. The registration 

address is: www.regonline.com/ 

2018acftribalconsultation. If you plan 

on providing testimony, please include 

the name of the office(s) you wish to 

address. 

Jeannie Hovland, 

Deputy Assistant Secretary for Native 

American Affairs. 

[FR Doc. 2018–18113 Filed 8–21–18; 8:45 am] 

BILLING CODE 4184–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Announcement of Intent To Issue one 

OPDIV-Initiated Supplement to BCFS 

Health and Human Services Under the 

Standing Announcement for 

Residential (Shelter) Services for 

Unaccompanied Children, HHS–2017– 

ACF–ORR–ZU–1132 

AGENCY: Unaccompanied Alien 

Children’s (UAC) Program, Office of 

Refugee Resettlement (ORR), 

Administration for Children and 

Families (ACF), U.S Department of 

Health and Human Services (HHS). 

ACTION: Notice of intent to issue one 

OPDIV-Initiated Supplement to BCFS 

Health and Human Services, San 

Antonio, TX under the UAC Program. 

SUMMARY: ACF, ORR, announces the 

intent to issue one OPDIV-Initiated 

Supplement to BCFS Health and Human 

Services, San Antonio, TX in the 

amount of $28,003,926. ORR has been 

identifying additional capacity to 

provide shelter for potential increases in 

apprehensions of Unaccompanied 

Children at the U.S. Southern Border. 

Planning for increased shelter capacity 

is a prudent step to ensure that ORR is 

able to meet its responsibility, by law, 

to provide shelter for Unaccompanied 

Alien Children referred to its care by the 

Department of Homeland Security 

(DHS). To ensure sufficient capacity to 

provide shelter to unaccompanied 

children referred to HHS, BCFS 

proposed to provide ORR with 850 beds 

in an expedited manner. 

DATES: Supplemental award funds will 

support activities through September 

13, 2018. 

FOR FURTHER INFORMATION CONTACT: 

Jallyn Sualog, Director, Division of 

Children’s Services, Office of Refugee 

Resettlement, 330 C Street SW, 

Washington, DC 20447. Phone: 202– 

401–4997. Email: DCSProgram@

acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: ORR is 

continuously monitoring its capacity to 

shelter the unaccompanied children 

referred to HHS, as well as the 

information received from interagency 

partners, to inform any future decisions 

or actions. 

ORR has specific requirements for the 

provision of services. Award recipients 

must have the infrastructure, licensing, 

experience, and appropriate level of 

trained staff to meet those requirements. 

The expansion of the existing program 

and its services through this 


amozie on DSK3GDR082PROD with NOTICES1